Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy | BMC Cancer | Full Text
Molecules | Free Full-Text | Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
Depleting arginine as a first-line cancer therapy
A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies | SpringerLink
Pegylated Arginine Deiminase Downregulates Colitis in Murine Models
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients | British Journal of Cancer
Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism
Experimental Cancer Drug Mimics Beneficial Fasting Effects
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
提前報喜! 北極星(6550) ADI-PEG20肺間皮癌三期試驗數據亮眼將陸續向美國FDA和歐盟討論藥證申請- 生技投資第一站-Genet 觀點
Polaris says new cancer treatment passes clinical trials - Taipei Times
ADI-PEG 20 reduces B16-F10 tumor growth as a single agent and in... | Download Scientific Diagram
Molecules | Free Full-Text | Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients | British Journal of Cancer
A trial of a new drug called ADI-PEG 20 with chemotherapy for people with mesothelioma (ATOMIC-Meso) | Cancer Research UK
Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug Designation in the United States and the European Union for the Treatment of Malignant Pleural Mesothelioma
北極星新藥，獲邀世界肺癌大會發表論文| TechNews 科技新報
Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism - ScienceDirect
![Model of [ 18 F]AFETP uptake in response to ADI-PEG20 treatment. In the... | Download Scientific Diagram](https://www.researchgate.net/publication/323689974/figure/fig4/AS:602979845537793@1520773006370/Model-of-18-FAFETP-uptake-in-response-to-ADI-PEG20-treatment-In-the-presence-of.png "Model of [ 18 F]AFETP uptake in response to ADI-PEG20 treatment. In the... | Download Scientific Diagram")
Model of [ 18 F]AFETP uptake in response to ADI-PEG20 treatment. In the... | Download Scientific Diagram
北極星ADI-PEG 20臨床試驗結果優力拚成為肝癌一線標準療法| Anue鉅亨- 台股新聞
Apoptosis induction by ADI-PEG 20 in resistant and sensitive AML in... | Download Scientific Diagram
Molecules | Free Full-Text | Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
Pegargiminase
Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase - ScienceDirect
北極星藥業(6550) - Warburg effect and ADI-PEG 20.jpg @ 穿夾腳拖的老黑胖的相簿:: 痞客邦::
![Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase - JTO Clinical and Research Reports](https://www.jtocrr.org/cms/asset/52536f9c-ac02-429a-a841-96cf93e0ec31/gr1.jpg "Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase - JTO Clinical and Research Reports")
Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase - JTO Clinical and Research Reports
